| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0021-9150(98)00318-9 |
| P698 | PubMed publication ID | 10208497 |
| P2093 | author name string | N Maeda | |
| W A Kuziel | |||
| T A Osahar | |||
| T C Dawson | |||
| P2860 | cites work | Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression | Q72690003 |
| Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity | Q72690025 | ||
| Oxidized low density lipoprotein and very low density lipoprotein enhance expression of monocyte chemoattractant protein-1 in rabbit peritoneal exudate macrophages | Q73589896 | ||
| Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice | Q77231603 | ||
| Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog | Q28245355 | ||
| Expression of both types of human interleukin-8 receptors on mature neutrophils, monocytes, and natural killer cells | Q28305983 | ||
| Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells | Q28509783 | ||
| Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice | Q28585385 | ||
| Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. | Q28590391 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E | Q29615236 | ||
| Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells | Q33667974 | ||
| Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E | Q33962949 | ||
| Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption | Q34181941 | ||
| Monocyte chemoattractant protein-1 in human atheromatous plaques | Q34203056 | ||
| Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension | Q34204885 | ||
| Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells | Q35822759 | ||
| Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor | Q36380911 | ||
| Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts | Q36393456 | ||
| Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice | Q36400287 | ||
| Quantitative assessment of atherosclerotic lesions in mice | Q36456167 | ||
| Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis | Q36586261 | ||
| Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells | Q37011453 | ||
| A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice | Q37377448 | ||
| Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions | Q37532544 | ||
| Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein | Q40343323 | ||
| Cell biology of atherosclerosis | Q40543287 | ||
| Molecular therapies for vascular diseases | Q40978349 | ||
| Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion | Q42494764 | ||
| Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma | Q42517095 | ||
| Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis | Q44121998 | ||
| Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis | Q46897070 | ||
| A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection | Q59068486 | ||
| Osteopetrosis, a New Recessive Skeletal Mutation on Chromosome 12 of the Mouse | Q67444875 | ||
| Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential | Q71011981 | ||
| Interleukin-8 production by macrophages from atheromatous plaques | Q71231737 | ||
| Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody | Q72080088 | ||
| Monocyte-endothelial cell interactions in vitro, with reference to the influence of interleukin-1 and tumor necrosis factor | Q72268513 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 205-211 | |
| P577 | publication date | 1999-03-01 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice | |
| P478 | volume | 143 |
| Q38936733 | A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy |
| Q73342747 | A study on the density and distribution of uterine Natural Killer cells at mid pregnancy in mice genetically-ablated for CCR2, CCR 5 and the CCR5 receptor ligand, MIP-1 alpha |
| Q58291513 | Activation of the JAK/STAT3 and PI3K/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells |
| Q33738515 | Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice |
| Q28392848 | Arsenic exacerbates atherosclerotic lesion formation and inflammation in ApoE-/- mice |
| Q37400830 | Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals |
| Q38985073 | Association between the monocyte chemoattractant protein-1 −2518G/A gene polymorphism and acute myocardial infarction patients among Egyptian population |
| Q36334120 | Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis |
| Q35102859 | Blockade of CCR2 ameliorates progressive fibrosis in kidney. |
| Q34186648 | Broad-spectrum chemokine inhibitors (BSCIs) and their anti-inflammatory effects in vivo |
| Q28587371 | CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis |
| Q33533950 | CCR2 and coronary artery disease: a woscops substudy |
| Q30891436 | CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice |
| Q33862217 | CD36 deletion improves recovery from spinal cord injury |
| Q35011812 | Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells |
| Q36532495 | Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. |
| Q34912596 | Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans |
| Q74481121 | Chemokine receptors |
| Q33772440 | Chemokines and atherosclerosis |
| Q39947134 | Chemokines and atherosclerosis: what Adam Smith has to say about vascular disease |
| Q28200068 | Chemokines and disease |
| Q37874834 | Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months. |
| Q51742202 | Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes. |
| Q28589623 | Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus |
| Q35314903 | Copper chelation by tetrathiomolybdate inhibits lipopolysaccharide-induced inflammatory responses in vivo |
| Q36168370 | Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome |
| Q35603166 | Critical role of chemokine (C-C motif) receptor 2 (CCR2) in the KKAy + Apoe -/- mouse model of the metabolic syndrome |
| Q34828549 | Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis |
| Q47833651 | Deletion of MCP-1 Impedes Pathogenesis of Acid Ceramidase Deficiency |
| Q36276106 | Differential effects of AT1 receptor and Ca2+ channel blockade on atherosclerosis, inflammatory gene expression, and production of reactive oxygen species |
| Q39730751 | Discovery of a 4-Azetidinyl-1-thiazoyl-cyclohexane CCR2 Antagonist as a Development Candidate |
| Q90625324 | Disruption of circadian rhythm by alternating light-dark cycles aggravates atherosclerosis development in APOE*3-Leiden.CETP mice |
| Q102053867 | EGFP-EGF1-conjugated poly (lactic-co-glycolic acid) nanoparticles as a carrier for the delivery of CCR2- shRNA to atherosclerotic macrophage in vitro |
| Q27313900 | Elucidation of monocyte/macrophage dynamics and function by intravital imaging |
| Q53481892 | Evaluation of (4-Arylpiperidin-1-yl)cyclopentanecarboxamides As High-Affinity and Long-Residence-Time Antagonists for the CCR2 Receptor. |
| Q37167792 | Experimental models investigating the inflammatory basis of atherosclerosis |
| Q51835921 | Expression and characterization of the chemokine receptor CCR2B from rhesus monkey. |
| Q35633338 | Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis |
| Q36660105 | Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis |
| Q52950456 | Freely associating with chemokine receptor 2 polymorphisms and atherosclerosis. |
| Q47598616 | Functional diversity of macrophages in vascular biology and disease. |
| Q34129761 | Gene targeting of chemokines and their receptors |
| Q34080318 | Genetic modifiers of atherosclerosis in mice |
| Q36755904 | Glycated LDL increases monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated chemotaxis |
| Q24336647 | Human LZIP induces monocyte CC chemokine receptor 2 expression leading to enhancement of monocyte chemoattractant protein 1/CCL2-induced cell migration |
| Q27332432 | Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression |
| Q79285484 | IL-6 is produced by splenocytes derived from CMV-infected mice in response to CMV antigens, and induces MCP-1 production by endothelial cells: a new mechanistic paradigm for infection-induced atherogenesis |
| Q37325024 | Immune and inflammatory mechanisms of atherosclerosis (*) |
| Q34168259 | Impact of macrophage inflammatory protein-1α deficiency on atherosclerotic lesion formation, hepatic steatosis, and adipose tissue expansion |
| Q44263791 | In CCR2-/- mice monocyte recruitment and egress of LDL cholesterol in vivo is impaired |
| Q33722663 | Induced Pluripotent Stem Cell-Derived Endothelial Cells Overexpressing Interleukin-8 Receptors A/B and/or C-C Chemokine Receptors 2/5 Inhibit Vascular Injury Response |
| Q23909537 | Inhalation exposure of gas-metal arc stainless steel welding fume increased atherosclerotic lesions in apolipoprotein E knockout mice |
| Q34980214 | Innate immunity and monocyte-macrophage activation in atherosclerosis. |
| Q42008009 | Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (or CCL2) in the regulation of metabolism |
| Q32055041 | Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes |
| Q74354815 | Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients |
| Q35797182 | Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproducts |
| Q34781705 | Lack of a significant role of P-Rex1, a major regulator of macrophage Rac1 activation and chemotaxis, in atherogenesis |
| Q42532089 | Lack of tyrosylprotein sulfotransferase activity in hematopoietic cells drastically attenuates atherosclerosis in Ldlr-/- mice |
| Q34275897 | Leukocyte CCR2 expression is associated with mini-mental state examination score in older adults |
| Q74340592 | Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegeneration |
| Q35127246 | Minireview: Adiposity, Inflammation, and Atherogenesis |
| Q37481208 | Monocyte chemoattractant protein-1 (MCP-1): an overview |
| Q37396582 | Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes. |
| Q35552775 | Monocyte chemotactic protein-1 promotes inflammatory vascular repair of murine carotid aneurysms via a macrophage inflammatory protein-1α and macrophage inflammatory protein-2-dependent pathway |
| Q30423561 | Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury |
| Q38077675 | Mouse models of atherosclerosis: explaining critical roles of lipid metabolism and inflammation |
| Q35815261 | Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury |
| Q35921028 | Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy |
| Q37503524 | Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal |
| Q55101116 | Obesity-induced Endothelial Dysfunction is Prevented by Neutrophil Extracellular Trap Inhibition. |
| Q36670249 | PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis |
| Q42789241 | Phospholipase C beta3 deficiency leads to macrophage hypersensitivity to apoptotic induction and reduction of atherosclerosis in mice |
| Q37131719 | Platelet chemokines in vascular disease |
| Q51287276 | Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice. |
| Q49603124 | Potential of anti-inflammatory agents for treatment of atherosclerosis |
| Q93002480 | Protective Effects of Angong Niuhuang Pill on Early Atherosclerosis in ApoE-/- Mice by Reducing the Inflammatory Response |
| Q41761265 | Quantitative structure activities relationships of some 2-mercaptoimidazoles as CCR2 inhibitors using genetic algorithm-artificial neural networks |
| Q39615447 | Rationally evolving MCP-1/CCL2 into a decoy protein with potent anti-inflammatory activity in vivo |
| Q34897655 | Reduced atherosclerotic lesion size in P-selectin deficient apolipoprotein E-knockout mice fed a chow but not a fat diet |
| Q27003124 | Regulation of atherogenesis by chemokines and chemokine receptors |
| Q35027759 | Regulation of chemokine expression in atherosclerosis |
| Q35541858 | Role of Monocytes in Atherogenesis |
| Q36346910 | Sexual dimorphism in rodent models of hypertension and atherosclerosis |
| Q34038256 | Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis |
| Q37002380 | Survival of monocytes and macrophages and their role in health and disease |
| Q92777021 | Synthesis, 3 H-labelling and in vitro evaluation of a substituted dipiperidine alcohol as a potential ligand for chemokine receptor 2 |
| Q84535196 | Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting |
| Q52885440 | The Anti-Atherosclerotic Effect of Naringin Is Associated with Reduced Expressions of Cell Adhesion Molecules and Chemokines through NF-κB Pathway. |
| Q78818552 | The SCID-hu Skin mouse as a model to investigate selective chemokine mediated homing of human T-lymphocytes to the skin in vivo |
| Q28360727 | The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation |
| Q73056519 | The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system |
| Q42175449 | The deleterious influence of tenofovir-based therapies on the progression of atherosclerosis in HIV-infected patients |
| Q36831073 | The downstream regulation of chemokine receptor signalling: implications for atherosclerosis |
| Q36174974 | The inflammation highway: metabolism accelerates inflammatory traffic in obesity |
| Q34470222 | The role of chemokines in human cardiovascular pathology: enhanced biological insights |
| Q37660659 | The role of chemokines in recruitment of immune cells to the artery wall and adipose tissue |
| Q40617645 | The state of macrophage differentiation determines the TNFα response to nitrated lipoprotein uptake |
| Q37981725 | Therapeutic strategies to deplete macrophages in atherosclerotic plaques |
| Q42947534 | Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment |
| Q24597133 | Two Hsp70 family members expressed in atherosclerotic lesions |
| Q35088170 | Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. |
| Q33864384 | Uremic conditions drive human monocytes to pro-atherogenic differentiation via an angiotensin-dependent mechanism. |
| Q37144135 | Validation of the circulating monocyte being representative of the cholesterol-loaded macrophage: biomediator activity |
| Q36197071 | Y-box binding protein 1 and RNase UK114 mediate monocyte chemoattractant protein 1 mRNA stability in vascular smooth muscle cells |
Search more.